Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

34071 - 34080 of 57753 results found

Use of Tenecteplase in Acute Ischemic Stroke in the Time of SARS-CoV-2

Date
Thursday, July 13, 2023 - 4:00 AM
Description
Tenecteplase (TNK) is a fibrinolytic drug that is administrated in a single bolus, recommended in eligible patients with acute ischemic stroke prior to mechanical thrombectomy. This study explores its usefulness in adverse situations, such as the

First International Conference on Public Health in Africa (CPHIA 2021)

Date
Thursday, July 13, 2023 - 4:00 AM
Description
The first international Conference on Public Health in Africa (CPHIA 2021) was hosted virtually by the African Union (AU) and Africa Centres for Disease Control and Prevention (Africa CDC) from 14-16 December 2021. This historic three-day conference

Cannabis-Involved Emergency Department Visits Among Persons Aged <25 Years Before and During the COVID-19 Pandemic - United States, 2019-2022

Date
Thursday, July 13, 2023 - 4:00 AM
Description
To understand trends in U.S. cannabis-involved emergency department (ED) visits (i.e., those for which cannabis use was documented in the chief complaint or a discharge diagnosis) among young persons aged <25 years during the COVID-19 pandemic, CDC used National Syndromic Surveillance Program data to examine changes in ED visits during 2019-2022. Mean weekly cannabis-involved ED visits among all young persons were higher during the COVID-19 pandemic in 2020, 2021, and 2022, compared with...

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults

Date
Thursday, July 13, 2023 - 4:00 AM
Description
In this phase 4 study we assessed boosting with fractional doses of heterologous COVID-19 vaccines in Brazilian adults primed with two doses of CoronaVac (Sinovac/Butantan, São Paulo, Brazil) at least 4 months previously. Participants received either